These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 37340919)

  • 41. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
    Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
    Front Oncol; 2022; 12():904464. PubMed ID: 35912258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.
    Huang X; Cao Y; Bao P; Zhu B; Cheng Z
    Cancer Med; 2023 Jan; 12(1):837-851. PubMed ID: 35634680
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
    Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
    Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
    Lin J; Cao Z; Yu D; Cai W
    Front Genet; 2021; 12():709133. PubMed ID: 34603375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. INHBA is a prognostic predictor for patients with colon adenocarcinoma.
    Li X; Yu W; Liang C; Xu Y; Zhang M; Ding X; Cai X
    BMC Cancer; 2020 Apr; 20(1):305. PubMed ID: 32293338
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
    Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
    BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis.
    Liu Q; Chen N; Liu L; Zheng Q; Liao W; Zhao M; Zeng J; Tang J
    Dis Markers; 2022; 2022():4492608. PubMed ID: 36168326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
    Yu J; Yang K; Zheng J; Sun X; Zhao W
    Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and validation of 12 immune-related genes as a prognostic signature for colon adenocarcinoma.
    Tang D; Huang W; Yang Z; Wu X; Sang X; Wang K; Cao G
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22852. PubMed ID: 34396630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
    Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
    Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma.
    Yuan Q; Zhang W; Shang W
    Front Endocrinol (Lausanne); 2022; 13():1045167. PubMed ID: 36518255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer.
    Liu Z; Liu Z; Zhou X; Lu Y; Yao Y; Wang W; Lu S; Wang B; Li F; Fu W
    Hum Genomics; 2022 Feb; 16(1):5. PubMed ID: 35109912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel machine learning model based on ubiquitin-related gene pairs and clinical features to predict prognosis and treatment effect in colon adenocarcinoma.
    Liang L; Liu L; Mai S; Chen Y
    Eur J Med Res; 2023 Jan; 28(1):41. PubMed ID: 36681855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma.
    Luo B; Lin J; Ni A; Cai W; Yu X; Wang M
    Front Oncol; 2022; 12():927028. PubMed ID: 36505872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the m6A-related lncRNA signature in predicting prognosis and immune response in patients with colon cancer.
    Chen S; Li X; Guo L; Zhang J; Li L; Wang X; Zhu Y; Wang J
    J BUON; 2021; 26(5):1931-1941. PubMed ID: 34761602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration.
    Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W
    Front Immunol; 2022; 13():959967. PubMed ID: 36177002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.